Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Wilms tumor of the kidney characterized by the predominance of the epithelial component. The epithelial cells may form papillary and tubular patterns and pseudorosettes.
Biomarker and diagnostic research for epithelial predominant Wilms' tumor has been reported in the published literature.
No clinical trials have been registered for epithelial predominant Wilms' tumor.
7 publications have been identified in PubMed for epithelial predominant Wilms' tumor. Research spans Case Report / Case Series (43%), Basic Science / Preclinical (29%), and Diagnostic / Biomarker (14%).
Vujanić GM (2026). [PMID: 41527366](https://pubmed.ncbi.nlm.nih.gov/41527366/). *Am J Surg Pathol*. [Basic Science / Preclinical]
Xu Y (2026). [PMID: 41099277](https://pubmed.ncbi.nlm.nih.gov/41099277/). *Histopathology*. [Epidemiology / Natural History]
Škarda J (2025). [PMID: 40177273](https://pubmed.ncbi.nlm.nih.gov/40177273/). *Front Med (Lausanne)*. [Case Report / Case Series]
Götz L (2025). [PMID: 39740515](https://pubmed.ncbi.nlm.nih.gov/39740515/). *Transl Oncol*. [Diagnostic / Biomarker]
Chan GJ (2024). [PMID: 37756569](https://pubmed.ncbi.nlm.nih.gov/37756569/). *Arch Pathol Lab Med*. [Case Report / Case Series]
Data assembled from 2 of 12 sources · Last updated Sep 20, 2026, 8:41 AM UTC
Chapman S (2024). [PMID: 39148862](https://pubmed.ncbi.nlm.nih.gov/39148862/). *Journal of kidney cancer and VHL*. [Case Report / Case Series]